Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Neuren Pharmaceuticals Limited ( (AU:NEU) ) has shared an update.
Neuren Pharmaceuticals has issued an online meeting guide for shareholders and appointed proxies ahead of an upcoming virtual shareholder meeting. The guide details technical requirements, including supported browsers and necessary identification such as shareholder or proxy numbers, and explains how investors can register, access the live webcast, view presentation slides, obtain electronic voting cards, and submit full or partial votes on meeting resolutions, underscoring the company’s move to streamline and formalize remote participation in its governance processes.
The most recent analyst rating on (AU:NEU) stock is a Buy with a A$19.10 price target. To see the full list of analyst forecasts on Neuren Pharmaceuticals Limited stock, see the AU:NEU Stock Forecast page.
More about Neuren Pharmaceuticals Limited
Neuren Pharmaceuticals Limited is a biotechnology company focused on developing therapeutics, with its shares held by individual and institutional investors who participate in corporate governance through shareholder meetings and proxy voting.
Average Trading Volume: 540,264
Technical Sentiment Signal: Sell
Current Market Cap: A$1.57B
Learn more about NEU stock on TipRanks’ Stock Analysis page.